Moderna MRNA
CEO: Stephane Bancel · Biotechnology · 5,700 employees
Compensation Breakdown
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $2.0M | — | $2.7M | $653K | $1.0M | $89K | $6.5M |
| 2024 | $2.0M | — | $1.7M | $1.3M | $998K | $49K | $6.1M |
| 2023 | $2.0M | $315K | $3.1M | $590K | $319K | $50K | $6.4M |
| 2022 | $1.9M | — | $2.5M | $873K | $955K | $114K | $6.8M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Frequently Asked Questions
Stephane Bancel, CEO of Moderna (MRNA), earns $6.5M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Moderna has a Pay-for-Performance Score of B (74/100). The company's 3-year total shareholder return is +17.2%, and the say-on-pay shareholder vote passed with 76.6% approval.
The CEO-to-median-worker pay ratio at Moderna is 197:1. The median worker at Moderna earns $33K per year, while CEO Stephane Bancel earns $6.5M in total compensation.
Moderna employs approximately 5,700 people. The company operates in the Biotechnology industry within the Healthcare sector, generating $6.7B in annual revenue.